The Department of Health - Abu Dhabi has announced a strategic partnership with the Fred Hutchinson Cancer Center, a renowned institution in cancer research and treatment. This collaboration, formalized in May 2026, aims to leverage the expertise of both parties to advance cancer research and develop personalized prevention strategies tailored to the needs of the Abu Dhabi community. The initiative aligns with the UAE’s broader healthcare goals of improving early detection and reducing cancer mortality rates by 2030.
Advancing Cancer Research
The partnership will focus on conducting cutting-edge research in cancer, with a particular emphasis on understanding the genetic and environmental factors that contribute to the disease. By combining their resources and expertise, the Department of Health - Abu Dhabi and Fred Hutchinson Cancer Center seek to identify innovative solutions for early detection, diagnosis, and treatment of cancer. Initial projects will prioritize genomic studies to map cancer prevalence among Abu Dhabi’s diverse population, including a focus on breast and colorectal cancers, which account for 30% of all cancer cases in the emirate. The collaboration will also establish a joint research lab at the Health Authority’s headquarters in Khalidiya, equipped with state-of-the-art sequencing technology.
Personalized Prevention Strategies
The collaboration also aims to develop and implement personalized prevention strategies that take into account the unique characteristics and risk factors of individuals in Abu Dhabi. This approach will enable healthcare providers to offer targeted interventions and screenings, ultimately reducing the burden of cancer in the community. A key initiative will be the launch of a mobile health app by early 2027, which uses AI to analyze patient data and recommend customized screening schedules. The program will initially target high-risk groups, including smokers and individuals with a family history of cancer, who comprise 40% of the emirate’s population. The Fred Hutchinson team will train 150 local healthcare professionals in precision medicine techniques to support these efforts.
Global Expertise, Local Impact
Fred Hutchinson Cancer Center, ranked among the top five cancer research institutions globally, brings decades of experience in translational research to the partnership. The center’s director, Dr. Lisa Richardson, emphasized during the May 2026 signing ceremony that “this collaboration bridges global innovation with Abu Dhabi’s commitment to healthcare excellence.” The partnership will also facilitate annual exchange programs for researchers, with the first cohort of 20 Emirati scientists set to visit Seattle in 2027. These exchanges will focus on immunotherapy development, a field where Fred Hutchinson has pioneered breakthroughs in treating leukemia and lymphoma.
Healthcare Infrastructure Expansion
As part of the partnership, the Department of Health - Abu Dhabi will invest AED 50 million over five years to expand its oncology wing at Al Rahba Hospital, a key referral center for cancer patients. The expansion, scheduled for completion by 2028, will add 50 new consultation rooms and a proton therapy center, a first for the UAE. The facility will serve 10,000 patients annually, with a 20% increase in capacity compared to current levels. The collaboration also includes a public awareness campaign, “Know Your Risk,” which will launch in September 2026 through social media and community workshops to educate residents on lifestyle factors contributing to cancer risk.
